Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
46.39%
Operating Margin
5.22%
Net Margin
-0.73%
Efficiency Metrics
Revenue per Expense Ratio
1.06
R&D as % of Revenue
0.25%
Earnings Quality
EBITDA Margin
7.08%
Income Tax Rate
151.29%
EPS
-0.0212000000
Balance Sheet Analysis
Current Ratio
1.26
Cash Ratio
0.62
Working Capital
$101.28M
Debt to Equity
0.06
Debt to Assets
3.04%
Equity Ratio
54.15%
Cash Flow Analysis
Operating Cash Flow Ratio
9.25%
Free Cash Flow Ratio
5.52%
CapEx to Revenue
3.73%
Dividends Paid
No dividends paid
Stock Buybacks
$2.63M
Total Shareholder Returns
$2.63M
Cash Position Change
-5.05%
Detailed Growth Metrics
Core Performance
Revenue
11.14%
Net Income
-105.82%
EPS
-105.73%
Operating Income
-38.73%
Operational Efficiency
R&D Expenses
-49.74%
SG&A Expenses
-20.89%
Operating Cash Flow
-20.37%
Free Cash Flow
-43.07%
Balance Sheet Health
Assets
9.56%
Debt
58.34%
Book Value per Share
-0.78%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
1.57%
Long Term Trends
3Y Revenue/Share
48.18%
5Y Revenue/Share
0.00%
3Y Dividend/Share
-100.00%
5Y Dividend/Share
0.00%